Global Health Limited (ASX: GLH) (“Global Health” or “the Group”) is pleased to release its Appendix 4C Cash Flow Report for the quarter ended 30 June 2026, and the accompanying Quarterly Business Activity Report. The financial performance commentary for the June-2026 quarter is relative to...
Global Health Limited (ASX: GLH) (“Global Health” or “the Group”) is pleased to release its Appendix 4C Cash Flow Report for the quarter ended 31 March 2026 (Q3 FY26), and the accompanying Quarterly Business Activity Report. The financial performance commentary for the Mar-26 quarter is...
Read the December Quarterly Business Report & Appendix 4C on the ASX here: 4C December 25 Quarter Cash Flow Report Amendment to cover page: 4C December 25 Quarter Cash Flow Report...
Read the 4C September 25 Quarter Cash Flow Report: 4C September 25 Quarter Cash Flow Report View on the ASX here: 4C September 25 Quarter Cash Flow Report...
Global Health Limited (ASX: GLH) (“Global Health” or “the Group”) is pleased to release its Appendix 4C Cash Flow Report for the quarter ended 30 June 2025, and the accompanying Quarterly Business Activity Report. The financial performance commentary for the June-2025 quarter is relative to...
Global Health Limited (ASX: GLH) (“Global Health” or “the Group”) is pleased to release its Appendix 4C Cash Flow Report for the quarter ended 31 March 2025 (Q3 FY25), and the accompanying Quarterly Business Activity Report. The financial performance commentary for the Mar-25 quarter is...
Dec-24 Quarter Highlights Customer Receipts up 22% from PCP to $3.025M for the Dec-24 Qtr. Operating and investing cashflow up 355% from PCP to $382K for the Dec-24 Qtr. December Half-Year (6 months to 31-Dec 2024):Operating & Investing Cashflow improves by 56% (up $683K) to...
Result highlights include: Annual Recurring Revenue up 13% on PCP Cash receipts up 13% on the Previous Corresponding Period (PCP) Net Operating and Investing cashflow reduced by 14% from PCP Group Cashflow deficit reduced by 28% from PCP Global Health Limited (ASX: GLH) (“Global Health” or...
Result highlights include: Operating Cashflow Growth: Operating cashflow in the June-24 quarter surged by 666% compared to June-23, reaching $419K. Strong Financial Position: Closing cash balance as of 30 June 2024 stood at $2.066M, inclusive of $596K in Convertible Notes. Successful Implementation of MasterCare: MasterCare...
Result highlights include: Year To Date (YTD) Revenue to March up 12% on the Previous Corresponding Period (PCP) Operating Cashflow improves by 69% from the PCP Group Cashflow improves by 61% from the PCP Global Health Limited (ASX: GLH) (“Global Health” or “the Group”) is pleased...